Journey Medical Corp
NASDAQ:DERM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Beijing Funshine Culture Media Co Ltd
SZSE:300860
|
CN |
Journey Medical Corp
Accounts Payable
Journey Medical Corp
Accounts Payable Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Payable | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Journey Medical Corp
NASDAQ:DERM
|
Accounts Payable
$9.3m
|
CAGR 3-Years
-37%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Accounts Payable
$12B
|
CAGR 3-Years
7%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Accounts Payable
$3.6B
|
CAGR 3-Years
6%
|
CAGR 5-Years
6%
|
CAGR 10-Years
9%
|
|
|
Pfizer Inc
NYSE:PFE
|
Accounts Payable
$5.2B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
4%
|
CAGR 10-Years
4%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Accounts Payable
$4.4B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
6%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Accounts Payable
$5.4B
|
CAGR 3-Years
41%
|
CAGR 5-Years
27%
|
CAGR 10-Years
15%
|
|
Journey Medical Corp
Glance View
Journey Medical Corp. operates as a commercial-stage pharmaceutical company, which engages in developing, acquiring, licensing and commercializing of dermatology products. The company is headquartered in Scottsdale, Arizona and currently employs 90 full-time employees. The company went IPO on 2021-11-12. The company is focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company provides nine products that help treat and heal common skin conditions, such as Qbrexza, Accutane, Targadox, Ximino, Exelderm Cream and Solution, Ceracade Skin Emulsion, Luxamend Wound Cream, AMZEEQ and ZILXI. Its product Qbrexza is a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, which is an oral isotretinoin drug for the treatment of severe recalcitrant severe acne; Targadox, which is an oral doxycycline drug for adjunctive therapy for acne; Ximino, which is an oral minocycline drug for the treatment of moderate to severe acne; Exelderm Cream and Solution is an antifungal intended for topical use; Ceracade Skin Emulsion is used to treat dry skin conditions; AMZEEQ is used for the treatment of acne and ZILXI, for the treatment of rosacea.
See Also
What is Journey Medical Corp's Accounts Payable?
Accounts Payable
9.3m
USD
Based on the financial report for Dec 31, 2025, Journey Medical Corp's Accounts Payable amounts to 9.3m USD.
What is Journey Medical Corp's Accounts Payable growth rate?
Accounts Payable CAGR 5Y
37%
Over the last year, the Accounts Payable growth was -44%. The average annual Accounts Payable growth rates for Journey Medical Corp have been -37% over the past three years , 37% over the past five years .
